Community Outreach and Engagement

社区外展和参与：项目摘要 西特曼癌症中心(SCC)的集水区横跨密苏里州和伊利诺伊州的82个县。这个 各县的健康覆盖率和总体癌症负担水平有很大差异。这个国家的人口 流域极其多样化，15%的人口生活在农村地区，29%的人口生活在医疗地区 服务不足区(MUA)。流域内少数民族人口占总人口的20.5%。 然而，非裔美国人的鳞癌患者生活在MUA的比例要高得多(31.3%)， 相比之下，白人患者(25.2%)。作为一个整体，我们的集水区携带着不成比例的高癌症 负担，晚期诊断率增加，癌症死亡率高。事实上，一个重要的 SCC集水区县的百分比属于美国乳腺癌、肺癌、前列腺癌和结直肠癌的最高四分位数 癌症死亡率。为了解决我们流域的差异和癌症负担，SCC调查人员已经 制定了量身定做的教育材料，建立了针对癌症的社区合作伙伴关系，参与了临床试验 监测系统，并扩大临床服务，作为SCC综合外展战略的一部分。SCC的 社区外展和参与(COE)组件建立在此基础上，目标是 伙伴关系，并确保所有癌症患者和社区都能从临床和科学中受益 预付款。SCC的COE组件解决并监控服务不足人群之间的差异， 特别是种族(少数民族)、地理位置(农村)、获得服务的机会(医疗服务不足的地区)以及他们 互动。SCC的COE组件被组织为内部咨询委员会(IAB)；社区咨询 委员会(CAB)；临床研究外展(CSO)团队；以及六名半全职同等职位的工作人员。这些 小组共同努力实现COE目标：(1)监测和评估癌症负担和相关 SCC集水区的差异；(2)加快实施外联、教育和临床 与社区合作，减少癌症负担和SCC中相关差异的资源 (3)支持减少癌症负担和SCC集水区相关差距的研究 通过：(3a)支持社区和健康差距研究；(3b)持续评价和 教育促进临床试验参与的多样性。为了实现这些目标，COE将在现有基础上 由于SCC作为供应商的关键作用而产生的强大的社区和区域伙伴关系 位于我们集水区的研究中心。通过实现上述目标，SCC将确保中心是最好的 应对癌症对我们流域的影响，并正在发展坚实的基础设施，以保持积极的 影响和加强鳞癌研究向临床的转化。这些目标合在一起，旨在减少 癌症负担和SCC集水区的相关差异。

COMMUNITY OUTREACH AND ENGAGEMENT: PROJECT SUMMARY The catchment area of Siteman Cancer Center (SCC) spans 82 counties across Missouri and Illinois. The counties exhibit significantly different levels of health coverage and overall cancer burden. The population of the catchment is extremely diverse, with 15% of the population living in a rural area, and 29% in a Medically Underserved Area (MUA). Minority populations in the catchment make up 20.5% of the total population. However, a significantly higher proportion of SCC patients who are African-American live in a MUA (31.3%), compared to White patients (25.2%). Our catchment area as a whole carries a disproportionately high cancer burden, with increased incidence of late stage diagnoses and a high cancer mortality. In fact, a significant percentage of SCC catchment counties fall within the highest US quartile for breast, lung, prostate, and colorectal cancer mortality. To address the disparities and cancer burden in our catchment, SCC investigators have developed tailored educational materials, cancer-specific community partnerships, a clinical trial participation monitoring system, and expanded clinical services as part of SCC’s Comprehensive Outreach Strategy. SCC’s Community Outreach and Engagement (COE) component builds on this foundation with the goal to sustain partnerships and assure that all cancer patients and communities can benefit from clinical and scientific advances. SCC’s COE component addresses and monitors disparities among underserved populations, specifically racial (minority), geography (rural), access to services (medically underserved areas), and their interaction. SCC’s COE component is organized into an Internal Advisory Board (IAB); a Community Advisory Board (CAB); a Clinical Studies Outreach (CSO) team; and six and one-half full-time equivalents staff. These groups work together to accomplish the COE aims: (1) Monitor and evaluate the cancer burden and related disparities in the SCC catchment; (2) Accelerate the implementation of outreach, education, and clinical resources in collaboration with communities to reduce the cancer burden and related disparities in the SCC catchment; and (3) Support research to reduce the cancer burden and related disparities in the SCC catchment through: (3a) Support for community-based and health disparities research, and (3b) Continuous evaluation and education to promote diversity in clinical trial participation. To achieve these aims, COE will build upon existing strong community and regional partnerships that have emanated from SCC’s critical role as a provider and research center in our catchment area. By achieving the above aims, SCC will ensure that the center is best addressing the impact of cancer in our catchment and is developing a solid infrastructure for sustaining positive impacts and strengthening translation of SCC research to clinical practice. Together, these aims work to reduce the cancer burden and related disparities in SCC’s catchment.